AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time, setting up regulatory filings. The ...

UPDATE (September 29, 2025): Trump has signed an executive order slapping a 10 percent tariff on softwood timber products and a 25 percent tariff on certain furniture items. The decisions follows an ...